A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir
(2023) Annual Meeting of French Society of Pharmacology and Therapeutics — Location: Limoges, France (12.June.2023)
Files
LemaitreetalAbiologicalpharmacologynetworktosecuretheriskofdrugdruginteractionwithnirmatrelvirritonavirabstr.pdf
Open Access - Adobe PDF
- 60.28 KB
Details
- Authors
- Affiliations
Citations
Lemaitre, F., Boland, L., Tron, C., Ruelland, A., Lelong-Boulouard, V., Baklouti, S., Goirand, F., Gambier, N., Boglion-Kerrien, C., Franck, B., Lalanne, S., Devresse, A., Briol, S., De Greef, J., Haufroid, V., & Verdier, M. (2023). A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir. Fundamental and Clinical Pharmacology, 37(suppl 1). https://hdl.handle.net/2078.5/266641 (Original work published 2023)